Floatz logo

CYCLOSPORIN A

Myelodysplastic Syndrome With Isolated Del(5q)

National Cancer Institute (NCI)protein_peptidePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Myelodysplastic Syndrome With Isolated Del(5q) cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Mayo Clinic
Phase 2BB
METHOTREXATE
National Cancer Institute (NCI)
Phase 3BB
TACROLIMUS
National Cancer Institute (NCI)
Phase 3BB
Cyclophosphamide
Fred Hutchinson Cancer Center
Phase 3BB
Busulphan
Fred Hutchinson Cancer Center
Phase 3B

View all 15 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →